SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-017308
Filing Date
2014-03-24
Accepted
2014-03-24 14:45:48
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 20-F v371545_20f.htm 20-F 1481354
2 EXHIBIT 12.1 v371545_ex12-1.htm EX-12.1 7936
3 EXHIBIT 12.2 v371545_ex12-2.htm EX-12.2 8068
4 EXHIBIT 13.1 v371545_ex13-1.htm EX-13.1 4263
5 EXHIBIT 13.2 v371545_ex13-2.htm EX-13.2 4355
12 GRAPHIC tpg2.jpg GRAPHIC 6047
  Complete submission text file 0001144204-14-017308.txt   8134129

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cltx-20131231.xml EX-101.INS 1155791
7 XBRL TAXONOMY EXTENSION SCHEMA cltx-20131231.xsd EX-101.SCH 70142
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cltx-20131231_cal.xml EX-101.CAL 25392
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cltx-20131231_def.xml EX-101.DEF 297298
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cltx-20131231_lab.xml EX-101.LAB 374582
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cltx-20131231_pre.xml EX-101.PRE 353658
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 20-F | Act: 34 | File No.: 001-36288 | Film No.: 14712912
SIC: 2834 Pharmaceutical Preparations